Hannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.
Institute of Hygiene and Environmental Medicine, Charité-University Medicine, Berlin, Germany.
PLoS One. 2024 Feb 26;19(2):e0297866. doi: 10.1371/journal.pone.0297866. eCollection 2024.
Vancomycin-resistant enterococci (VRE) occur in hospitalized patients, causing both infection and colonization. In recent years, there has been an increase in VRE in German and other hospitals, raising the question of how to control this epidemic best. To better understand the specific epidemiology and to guide infection control, we conducted a retrospective cohort study analyzing all patients with VRE at Hannover Medical School, a tertiary university clinic in Germany that specializes in solid organ transplantation. Epidemiologic and clinical characteristics of patients with VRE from 2015-2017 were collected. Basic epidemiologic parameters, including VRE incidence and incidence density, were calculated. Independent risk factors for nosocomial VRE infection compared to colonization were assessed using a logistic regression model. There were 1,492 VRE cases corresponding to 822 individual patients. The incidence was 0.8 VRE cases per 100 cases. A total of 536 (35.9%) of the 1,492 VRE cases were acquired nosocomially. Of the 1,492 cases, 912 cases had VRE-positive samples (894 Enterococcus (E.) faecium and 18 E. faecalis) in our hospital laboratory and the remaining cases were known VRE carriers. The vanB-phenotype was observed in 369 of the 894 (41.3%) E. faecium isolates and in 6 of the 18 (33.3%) E. faecalis isolates. There was an increase over time in the vanB-phenotype proportion in E. faecium (2015: 63 of 171, 36.8%, 2016: 115 of 322, 35.7% and 2017: 191 of 401, 47.6%). A total of 107 cases had a VRE infection (7.2% of all VRE cases) according to the criteria of the German National Reference Center for Surveillance of Nosocomial Infections. The remaining cases were only colonized. Among other factors, leukocytopenia (<1,000/μL), the use of a central venous catheter and the visceral surgery medical specialty were independently associated with nosocomial VRE infection. VRE imposed a relevant and increasing infection control burden at our hospital. Nosocomial VRE infection was predominantly found in certain medical specialties, such as hematology and oncology and visceral surgery. Infection control efforts should focus on these highly affected patient groups/specialties.
耐万古霉素肠球菌(VRE)发生在住院患者中,引起感染和定植。近年来,德国和其他医院的 VRE 有所增加,这引发了如何最好地控制这种流行的问题。为了更好地了解具体的流行病学并指导感染控制,我们对德国汉诺威医学院的所有 VRE 患者进行了回顾性队列研究,该医学院是一家专门从事实体器官移植的三级大学诊所。收集了 2015-2017 年 VRE 患者的流行病学和临床特征。计算了基本的流行病学参数,包括 VRE 的发病率和发病率密度。使用逻辑回归模型评估了与定植相比,导致医院获得性 VRE 感染的独立危险因素。共有 1492 例 VRE 病例对应 822 名个体患者。发病率为每 100 例 0.8 例 VRE 病例。1492 例 VRE 中有 536 例(35.9%)是医院获得性的。在 1492 例中,我院实验室有 912 例 VRE 阳性样本(894 株粪肠球菌(E. faecium)和 18 株屎肠球菌(E. faecalis)),其余病例为已知的 VRE 携带者。在 894 株粪肠球菌中观察到 vanB 表型 369 株(41.3%),18 株屎肠球菌中观察到 6 株(33.3%)。粪肠球菌的 vanB 表型比例随时间增加(2015 年:171 例中的 63 例,36.8%,2016 年:322 例中的 115 例,35.7%,2017 年:401 例中的 191 例,47.6%)。根据德国国家医院感染监测中心的标准,共有 107 例 VRE 感染(所有 VRE 病例的 7.2%)。其余病例仅定植。白细胞减少症(<1000/μL)、使用中心静脉导管和内脏手术医疗专业是与医院获得性 VRE 感染独立相关的其他因素。VRE 在我们医院造成了相当大且不断增加的感染控制负担。医院获得性 VRE 感染主要发生在某些医学专业,如血液科和肿瘤科以及内脏外科。感染控制工作应重点关注这些受影响严重的患者群体/专业。